These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26021407)

  • 1. Glomerular structure in diabetes - can it predict the future?
    White K
    Am J Nephrol; 2015; 41(4-5):275-6. PubMed ID: 26021407
    [No Abstract]   [Full Text] [Related]  

  • 2. Podocyte structural parameters do not predict progression to diabetic nephropathy in normoalbuminuric type 1 diabetic patients.
    Harindhanavudhi T; Parks A; Mauer M; Caramori ML
    Am J Nephrol; 2015; 41(4-5):277-83. PubMed ID: 26021523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celecoxib modifies glomerular basement membrane, mesangium and podocytes in OVE26 mice, but ibuprofen is more detrimental.
    Nasrallah R; Robertson SJ; Karsh J; Hébert RL
    Clin Sci (Lond); 2013 Jun; 124(11):685-94. PubMed ID: 23305077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
    Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AJKD Atlas of Renal Pathology: diabetic nephropathy.
    Najafian B; Fogo AB; Lusco MA; Alpers CE
    Am J Kidney Dis; 2015 Nov; 66(5):e37-8. PubMed ID: 26498421
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal lesions predict progression of diabetic nephropathy in type 1 diabetes.
    Caramori ML; Parks A; Mauer M
    J Am Soc Nephrol; 2013 Jun; 24(7):1175-81. PubMed ID: 23687360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte number in normotensive type 1 diabetic patients with albuminuria.
    White KE; Bilous RW; Marshall SM; El Nahas M; Remuzzi G; Piras G; De Cosmo S; Viberti G
    Diabetes; 2002 Oct; 51(10):3083-9. PubMed ID: 12351451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy.
    Thomson SE; McLennan SV; Kirwan PD; Heffernan SJ; Hennessy A; Yue DK; Twigg SM
    J Diabetes Complications; 2008; 22(4):284-94. PubMed ID: 18413184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?
    Marshall CB
    Am J Physiol Renal Physiol; 2016 Nov; 311(5):F831-F843. PubMed ID: 27582102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanostructural features of diabetic podocytopathy.
    Mandache E; Penescu M
    Rom J Morphol Embryol; 2012; 53(1):23-7. PubMed ID: 22395495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Etiopathogenesis of early stages of diabetic nephropathy].
    Pynka S; Czekolski S
    Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):830-5. PubMed ID: 2096378
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel podocyte protein, R3h domain containing-like, inhibits TGF-β-induced p38 MAPK and regulates the structure of podocytes and glomerular basement membrane.
    Ishikawa T; Takemoto M; Akimoto Y; Takada-Watanabe A; Yan K; Sakamoto K; Maezawa Y; Suguro M; He L; Tryggvason K; Betsholtz C; Yokote K
    J Mol Med (Berl); 2021 Jun; 99(6):859-876. PubMed ID: 33620517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early glomerulopathy is present in young, type 1 (insulin-dependent) diabetic patients with microalbuminuria.
    Bangstad HJ; Osterby R; Dahl-Jørgensen K; Berg KJ; Hartmann A; Nyberg G; Frahm Bjørn S; Hanssen KF
    Diabetologia; 1993 Jun; 36(6):523-9. PubMed ID: 8335174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPK signalling: Implications for podocyte biology in diabetic nephropathy.
    Szrejder M; Piwkowska A
    Biol Cell; 2019 May; 111(5):109-120. PubMed ID: 30702162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys.
    Fioretto P; Mauer SM; Bilous RW; Goetz FC; Sutherland DE; Steffes MW
    Lancet; 1993 Nov; 342(8881):1193-6. PubMed ID: 7901527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of glomerulopathy predicts long-term urinary albumin excretion rate in patients with type 1 diabetes and microalbuminuria.
    Bangstad HJ; Osterby R; Hartmann A; Berg TJ; Hanssen KF
    Diabetes Care; 1999 Feb; 22(2):314-9. PubMed ID: 10333951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.
    Wang Y; Heilig K; Saunders T; Minto A; Deb DK; Chang A; Brosius F; Monteiro C; Heilig CW
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F99-F111. PubMed ID: 20375117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capillary basement membranes and diabetes mellitus.
    N Engl J Med; 1985 Oct; 313(16):1024-5. PubMed ID: 4047102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.